Admission levels of serum Gc-globulin: Redictive value in fulminant hepatic failure

Hepatology

Volumn 23, Issue 4, 1996, Pages 713-718

  Schiødt, Frank V ^a   Bondesen, Stig ^a   Petersen, Inger ^a   Dalhoff, Kim ^a   Ott, Peter ^a   Tygstrup, Niels ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; PARACETAMOL; PLASMA PROTEIN; VITAMIN D BINDING PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; SURVIVAL RATE;

ACETAMINOPHEN; ADULT; AGED; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; VITAMIN D-BINDING PROTEIN;

EID: 0029985995     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510230409     Document Type: Article

References (26)

1. Lee WM. Acute liver failure. N Engl J Med 1993;329:1862-1872.
2. Lidofsky SD. Liver transplantation for fulminant hepatic failure. Gastroenterol Clin North Am 1993;22:257-269.
3. Fingerote RJ, Bain VG. Fulminant hepatic failure. Am J Gastroenterol 1993;88:1000-1010.
4. Riegler JL, Lake JR. Fulminant hepatic failure. Med Clin North Am 1993;77:1057-1083.
5. Smith SL, Ciferni M. Liver transplantation for acute hepatic failure: a review of clinical experience and management. Am J Crit Care 1993;2:137-144.
6. Christensen E, Bremmelgaard A, Bahnsen M, Andreasen PB, Tygstrup N. Prediction of fatality in fulminant hepatic failure. Scand J Gastroenterol 1984;19:90-96.
7. Tygstrup N, Ranek L. Assessment of prognosis in fulminant hepatic failure. Semin Liver Dis 1986;6:129-137.
8. Scaiola A, MacMathuna P, Langley PG, Gove CD, Hughes RD, Williams R. Determination of the ketone body ratio in fulminant hepatic failure. Hepatogastroenterology 1990;37:413-416.
9. Harrison PM, O'Grady JG, Keays RT, Alexander GJ, Williams R. Serial prothomhin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ 1990;301:964-966.
10. Pereira LM, Langley PG, Hayllar KM, Tredger JM, Williams R. Coagulation factors V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators. Gut 1992;33:98-102.
11. Sekiyama K, Yoshiba M, Inoue K, Sugata F. Prognostic value of hepatic volumetry in fulminant hepatic failure. Dig Dis Sci 1994;39:240-244.
12. O'Grady JG, Alexander G J, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445.
13. Lind SE, Smith DB, Janmey PA, Stossel TP. Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation. J Clin Invest 1986;78:736-742.
14. Harper KD, McLeod JF, Kowalski MA, Haddad JG. Vitamin D binding protein sequesters monomeric actin in the circulation of the rat. J Clin Invest 1987;79:1365-1370.
15. Goldschmidt-Clermont PJ, Van Baelen H, Bouillon R, Shook TE, Williams MH, Nel AE, Galbraith RM. Role of group-specific component (vitamin D binding protein) in clearance of actin from the circulation in the rabbit. J Clin Invest 1988;81:1519-1527.
16. Lee WM, Galbraith RM. The extracellular actin-scavenger system and actin toxicity. N Engl J Med 1992;326:1335-1341.
17. Haddad JD, Harper KD, Guoth M, Pietra GG, Sanger JW. Angiopathic consequences of saturating the plasma scavenger system for actin. Proc Natl Acad Sci U S A 1990;87:1381-1385.
18. Lee WM, Emerson DL, Young WO, Goldschmidt-Clermont PJ, Jollow DJ, Galbraith RM. Diminished serum Gc (vitamin D-binding protein) levels and increased Gc:G-actin complexes in a hamster model of fulminant hepatic necrosis. HEPATOLOGY 1987;7:825-830.
19. Young WO, Goldschmidt-Clermont PJ, Emerson DL, Lee WM, Jollow DJ, Galbraith RM. Correlation between extent of liver damage in fulminant hepatic necrosis and complexing of circulating group-specific component (vitamin D-binding protein). J Lab Clin Med 1987;110:83-90.
20. Lee WM, Emerson DL, Werner PAM, Arnoud P, Goldschmidt-Clermont PJ, Galbraith RM. Decreased serum group-specific component protein levels and complexes with actin in fulminant hepatic necrosis. HEPATOLOGY 1985;5:271-275.
21. Goldschmidt-Clermont PJ, Lee WM, Galbraith RM. Proportion of circulating Gc (vitamin D-binding protein) in complexed form: relation to clinical outcome in fulminant hepatic necrosis. Gastroenterology 1988;94:1454-1458.
22. Goldschmidt-Clermont PJ, Galbraith RM, Emerson DL, Werner PA, Nel AE, Lee WM. Accurate quantitation of native Gc protein in serum and estimation of endogenous Gc:G-actin complexes by rocket immunoelectrophoresis. Clin Chim Acta 1985;148:173-183.
23. Lee WM, Galbraith RM, Watt GH, Hughes RD, McIntire DD, Hoffman BJ, Williams R. Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. HEPATOL-OGY 1995;21:101-105.
24. Harrison PM, Keays R, Bray GP, Alexander GJM, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990;335:1572-1573.
25. Schiødt FV, Bondesen S, Tygstrup N. Serial measurements of serum Gc-globulin in acetaminophen intoxication. Eur J Gastroenterol Hepatol 1995;7:635-640.
26. Lake JR, Sussman NL. Determining prognosis in patients with fulminant hepatic failure: when you absolutely, positively have to know the answer (Editorial). HEPATOLOGY 1995;21:879-882.